Database of Short Tandem Repeats
Locus | Repeat type | Motif | Region | Normal | Intermediate | Pathogenic | Inheritance | Disease |
---|---|---|---|---|---|---|---|---|
ABCD3 | Standard | GCC | 5′ UTR | – | – | ≥118 | AD | Oculopharyngodistal myopathy (OPDM) |
AFF2 | Standard | CCG | 5′ UTR | 6-25 | – | ≥200 | XLR | FRAXE mental retardation (FRAXE) |
AR | Standard | CAG | Coding | 17-35 | – | ≥40 | XLR | Spinal and bulbar muscular atrophy (SBMA) |
ARX_1 | Imperfect GCN | GCN | Coding | 16 16 | – – | ≥23 ≥18 | XLR XLR | Developmental and epileptic encephalopathy-1 (DEE1) X-linked mental retardation with or without seizures (MRXARX) |
ARX_2 | Imperfect GCN | GCN | Coding | 12 12 12 | – – – | ≥20 ≥20 ≥23 | XLR XLR XLR | Developmental and epileptic encephalopathy-1 (DEE1) Partington syndrome (PRTS) X-linked mental retardation with or without seizures (MRXARX) |
ATXN10 | Standard | ATTCT | Intron | 10-29 | 30-799 | ≥800 | AD | Spinocerebellar ataxia 10 (SCA10) |
ATXN8OS | Standard | CTG | 3′ UTR | 2-37 | 38-79 | ≥80 | AD | Spinocerebellar ataxia 8 (SCA8) |
ATN1 | Standard | CAG | Coding | 7-23 | – | ≥49 | AD | Dentatorubral-pallidoluysian atrophy (DRPLA) |
ATXN1 | Standard | CAG | Coding | 6-32 | 36-38 | ≥39 | AD | Spinocerebellar ataxia 1 (SCA1) |
ATXN2 | Standard | CAG | Coding | 13-31 | 32-34 | ≥35 | AD | Spinocerebellar ataxia 2 (SCA2) |
ATXN3 | Standard | CAG | Coding | 12-44 | 45-55 | ≥56 | AD | Spinocerebellar ataxia 3 (SCA3) |
ATXN7 | Standard | CAG | Coding | 4-35 | 28-35 | ≥36 | AD | Spinocerebellar ataxia 7 (SCA7) |
BEAN1 | Nested | TGGAA | Intron | 0 | – | ≥500 | AD | Spinocerebellar ataxia 31 (SCA31) |
C9ORF72 | Standard | GGGGCC | Intron | 1-19 | 20-23 | ≥24 | AD | Amyotrophic lateral sclerosis and/or frontotemporal dementia (FTDALS1) |
CACNA1A | Standard | CAG | Coding | 4-18 | 19 | ≥21 | AD | Spinocerebellar ataxia 6 (SCA6) |
CBL | Standard | CCG | 5′ UTR | 8-80 | 85-100 | ≥101 | NI | Jacobsen syndrome (JBS) |
CNBP | Standard | CCTG | Intron | ≤29 | 30-55 | ≥55 | AD | Myotonic dystrophy 2 (DM2) |
COMP | Standard | GAC | Coding | 5 5 | – – | ≥6 ≥7 | AD AD | Multiple epiphyseal dysplasia (EDM1) Pseudoachondroplasia (PSACH) |
CSTB | VNTR | CCCCGC... | Promoter | 2-3 | – | ≥30 | AR | Myoclonic epilepsy of Unverricht and Lundborg (ULD) |
DAB1 | Nested | ATTTC | Intron | 0 | – | ≥31 | AD | Spinocerebellar ataxia 37 (SCA37) |
DIP2B | Standard | CGG | 5′ UTR | 6-23 | – | ≥273 | AD | Mental retardation, FRA12A type (MRFRA12A) |
DMD | Standard | GAA | Intron | 11-33 | – | ≥59 | XLR | Duchenne muscular dystrophy (DMD) |
DMPK | Standard | CTG | 3′ UTR | 5-34 | 35-49 | ≥50 | AD | Myotonic dystrophy 1 (DM1) |
EIF4A3 | VNTR | TCGGCA... | 5′ UTR | 3-12 | – | ≥15 | AR | Richieri-Costa-Pereira syndrome (RCPS) |
FGF14 | Standard | GAA | Intron | 8-249 | – | ≥250 | AD | Spinocerebellar ataxia 27B (SCA27B) |
FMR1 | Standard | CGG | 5′ UTR | 6-40 6-40 | 41-54 41-54 | 55-200 ≥201 | XLD XLD | Fragile X tremor/ataxia syndrome (FXTAS) Fragile X Syndrome (FXS) |
FOXL2 | Imperfect GCN | GCN | Coding | 14 | – | ≥19 | AD | Blepharophimosis, ptosis, and epicanthus inversus syndrome (BPES) |
FXN | Standard | GAA | Intron | 5-30 | – | ≥70 | AR | Friedreich ataxia (FRDA) |
GIPC1 | Standard | GGC | 5′ UTR | 12-32 | – | ≥73 | AD | Oculopharyngodistal myopathy 2 (OPDM2) |
GLS | Standard | GCA | 5′ UTR | 5-26 | – | ≥680 | AR | Glutaminase deficiency with impaired intellectual development and progressive ataxia (GD) |
HOXA13_1 | Imperfect GCN | GCN | Coding | 14 | – | ≥22 | AD | Hand-foot-genital syndrome (HFG) |
HOXA13_2 | Imperfect GCN | GCN | Coding | 12 | – | ≥18 | AD | Hand-foot-genital syndrome (HFG) |
HOXA13_3 | Imperfect GCN | GCN | Coding | 18 | – | ≥24 | AD | Hand-foot-genital syndrome (HFG) |
HOXD13 | Imperfect GCN | GCN | Coding | 15 | – | ≥22 | AD | Synpolydactyly (SPD) |
HTT | Standard | CAG | Coding | 9-26 | 27-35 | ≥36 | AD | Huntington's disease (HD) |
JPH3 | Standard | CTG | 3′ UTR | 6-27 | – | ≥41 | AD | Huntington disease-like 2 (HDL2) |
LRP12 | Standard | CGG | 5′ UTR | 13-45 | – | ≥93 | AD | Oculopharyngodistal myopathy 1 (OPDM1) |
MARCHF6 | Nested | TTTCA | Intron | 0 | – | ≥668 | AD | Familial adult myoclonic epilepsy 3 (FAME3) |
NIPA1 | Standard | GCG | 5′ UTR | 6-10 | – | ≥11 | AD | Amyotrophic lateral sclerosis (ALS) |
NOTCH2NLC | Standard | GGC | 5′ UTR | 7-39 4-41 | – – | ≥90 ≥60 | AD AD | Neuronal intranuclear inclusion disease (NIID) Hereditary essential tremor type 6 (ETM6) |
NOP56 | Standard | GGCCTG | Intron | 3-14 | – | ≥25 | AD | Spinocerebellar ataxia 36 (SCA36) |
NUTM2B-AS1 | Standard | CGG | Noncoding transcript | 3-16 | – | ≥700 | AD | Oculopharyngeal myopathy with leukoencephalopathy 1 (OPML1) |
PABPN1 | Standard | GCG | Coding | 6 | – | ≥7 | AD or AR | Oculopharyngeal muscular dystrophy (OPMD) |
PHOX2B | Imperfect GCN | GCN | Coding | 20 | – | ≥24 | AD | Central hypoventilation syndrome (CCHS) |
PPP2R2B | Standard | CAG | 5′ UTR | 7-31 | – | ≥51 | AD | Spinocerebellar ataxia 12 (SCA12) |
PRNP | VNTR | CCTCAT... | Coding | 5 | – | ≥10 | AD | Creutzfeldt-Jakob Disease (CJD) |
PRDM12 | Standard | GCC | Coding | ≤14 | – | ≥18 | AR | Hereditary sensory and autonomic neuropathy type VIII (HSAN8) |
RAPGEF2 | Nested | TTTCA | Intron | 0 | – | ≥60 | AD | Familial adult myoclonic epilepsy 7 (FAME7) |
RFC1 | Replaced | AAGGG ... | Intron | 0 | – | ≥400 | AR | Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) |
RILPL1 | Standard | GGC | 5′ UTR | 4-20 | – | ≥135 | AD | Oculopharyngodistal myopathy 4 (OPDM4) |
RUNX2 | Imperfect GCN | GCN | Coding | 17 | – | ≥20 | AD | Cleidocranial dysplasia (CCD) |
SAMD12 | Nested | TTTCA | Intron | 0 | – | ≥100 | AD | Familial adult myoclonic epilepsy 1 (FAME1) |
SOX3 | Imperfect GCN | GCN | Coding | 15 15 | – – | ≥26 ≥22 | XLR XLR | X-linked mental retardation with isolated growth hormone (XLMR) X-linked panhypopituitarism (PHPX) |
STARD7 | Nested | ATTTC | Intron | 0 | – | ≥274 | AD | Familial adult myoclonic epilepsy 2 (FAME2) |
TBP | Standard | CAG | Coding | 25-42 | – | ≥43 | AD | Spinocerebellar ataxia 17 (SCA17) |
TBX1 | Imperfect GCN | GCN | Coding | 15 | – | ≥25 | AD | Tetralogy of Fallot (TOF) |
TCF4 | Standard | CTG | Intron | ≤31 | – | ≥50 | AD | Fuchs endothelial corneal dystrophy-3 (FECD3) |
THAP11 | Standard | CAG | Coding | 20-38 | – | ≥47 | AD | Spinocerebellar ataxia (SCA) |
TNRC6A | Nested | TTTCA | Intron | 0 | – | ≥1100 | AD | Familial adult myoclonic epilepsy 6 (FAME6) |
VWA1 | VNTR | GGCGCG... | Coding | 2 | – | ≥3 | AR | Hereditary motor neuropathy (HMNR7) |
XYLT1 | Standard | GGC | 5′ UTR | 9-20 | – | ≥110 | AR | Desbuquois dysplasia-2 (DBQD2) |
YEATS2 | Nested | TTTCA | Intron | 0 | – | ≥1000 | AD | Familial adult myoclonic epilepsy 4 (FAME4) |
ZFHX3 | Standard | GGC | Coding | 14-31 | – | ≥42 | AD | Spinocerebellar ataxia 4 (SCA4) |
ZIC2 | Imperfect GCN | GCN | Coding | 15 | – | ≥25 | AD | Holoprosencephaly 5 (HPE5) |
ZIC3 | Standard | GCC | Coding | 10 | – | ≥12 | XLR | X-linked VACTERL syndrome (VACTERLX) |